Question 1

What is metabolic syndrome?

Accepted Answer

Metabolic syndrome is a cluster of conditions — abdominal obesity, elevated blood pressure, elevated fasting glucose, elevated triglycerides, and low HDL cholesterol — that occur together and are associated with increased risk of cardiovascular disease and type 2 diabetes. A diagnosis is typically made when three or more criteria are present.

Question 2

What is insulin resistance?

Accepted Answer

Insulin resistance is a state in which the body's cells respond less efficiently to insulin. The pancreas compensates by secreting more insulin to keep blood glucose in range. Over time this compensation can be associated with weight gain, dyslipidemia, fatty liver, and progression to prediabetes or type 2 diabetes.

Question 3

Can metabolic disease be prevented?

Accepted Answer

Many metabolic conditions can be delayed or, in some cases, prevented. Randomized trials such as the Diabetes Prevention Program have shown that structured lifestyle changes substantially reduce progression from prediabetes to type 2 diabetes. Individual results vary and depend on baseline risk.

Question 4

What is the relationship between obesity and type 2 diabetes?

Accepted Answer

Excess adiposity — especially visceral and ectopic fat — is one of the strongest modifiable contributors to insulin resistance, which is a key driver of type 2 diabetes. Not everyone with obesity develops diabetes and not everyone with diabetes has obesity, but the association is strong at the population level.

Question 5

What role do hormones play in weight?

Accepted Answer

Hormones such as insulin, GLP-1, ghrelin, leptin, and others regulate hunger, satiety, and how energy is stored and used. Body weight is not regulated by willpower alone; it is biologically defended, which is one reason sustained change usually requires sustained intervention.

Question 6

What is prediabetes?

Accepted Answer

Prediabetes describes blood glucose levels that are higher than normal but not yet in the diabetes range. It is typically diagnosed by impaired fasting glucose (100–125 mg/dL), impaired glucose tolerance (2-hour OGTT 140–199 mg/dL), or A1C 5.7–6.4%. It is an important window for intervention.

Question 7

What is fatty liver disease (MASLD)?

Accepted Answer

MASLD — previously called NAFLD — is excess fat in the liver in the context of metabolic risk factors. A subset of patients develop inflammation (MASH), fibrosis, or cirrhosis. MASLD is closely linked to insulin resistance and increases cardiovascular risk.

Question 8

How is obesity diagnosed?

Accepted Answer

Obesity is commonly screened with body mass index (BMI). BMI is imperfect at the individual level — it does not distinguish muscle from fat — so clinicians often consider waist circumference, body composition, and comorbidities together.

Question 9

Is BMI a reliable measure?

Accepted Answer

BMI is a useful population screening tool but a blunt individual measure. Athletes can have high BMI from muscle; some people with normal BMI have significant visceral fat. Additional assessment is often warranted.

Question 10

What is metabolic surgery?

Accepted Answer

Metabolic surgery refers to gastrointestinal procedures performed primarily to improve metabolic disease — most commonly type 2 diabetes — alongside or independent of weight loss. Sleeve gastrectomy and Roux-en-Y gastric bypass are the most common.

Question 11

What is the difference between bariatric and metabolic surgery?

Accepted Answer

The two terms describe overlapping procedures. 'Bariatric' historically emphasizes weight loss; 'metabolic' emphasizes improvements in conditions such as type 2 diabetes. The same operations may be called either depending on the indication.

Question 12

What are GLP-1 medications?

Accepted Answer

GLP-1 receptor agonists are a class of medications that mimic the natural incretin hormone GLP-1. They are FDA-approved for type 2 diabetes and, at higher doses, for chronic weight management. Side effects, contraindications, and access vary.

Question 13

Can type 2 diabetes go into remission?

Accepted Answer

Some patients with type 2 diabetes achieve remission — typically defined as A1C below the diabetes range without glucose-lowering medication. Remission is more likely with substantial sustained weight loss, particularly earlier in the disease course. Remission is not a cure and ongoing monitoring is required.

Question 14

Is metabolic disease genetic?

Accepted Answer

Genetics influence susceptibility, but environment and lifestyle play a major role. A family history of type 2 diabetes, hypertension, or cardiovascular disease raises individual risk, which makes earlier screening and prevention more important.

Question 15

Does exercise help if I do not lose weight?

Accepted Answer

Yes. Regular physical activity improves insulin sensitivity, blood pressure, lipids, mood, and cardiovascular fitness even in the absence of weight change. Guidelines recommend at least 150 minutes of moderate-intensity activity per week plus muscle-strengthening on two or more days.

Question 16

How does sleep affect metabolic health?

Accepted Answer

Short or irregular sleep, and untreated sleep apnea, are associated with insulin resistance, weight gain, and cardiovascular risk. Improving sleep is often an under-appreciated component of metabolic care.

Question 17

What is hypertension's role in metabolic disease?

Accepted Answer

Hypertension frequently co-occurs with insulin resistance, obesity, and dyslipidemia, and it independently raises cardiovascular risk. Treating one component often improves others.

Question 18

What lab tests are commonly used?

Accepted Answer

Common labs include fasting lipid panel, fasting glucose and/or A1C, liver enzymes (ALT/AST), and — when indicated — fasting insulin, thyroid panel, and noninvasive liver fibrosis markers (e.g., FIB-4).

Question 19

What is visceral fat?

Accepted Answer

Visceral fat is adipose tissue stored around abdominal organs. It is metabolically more active than subcutaneous fat and is more strongly associated with insulin resistance and cardiovascular risk.

Question 20

Is medication a substitute for lifestyle change?

Accepted Answer

No. Medications work best alongside nutrition, activity, sleep, and behavioral support. Even highly effective therapies do not eliminate the value of foundational lifestyle change.

Question 21

How quickly can metabolic markers improve?

Accepted Answer

Many markers — blood pressure, triglycerides, fasting glucose, liver enzymes — can improve within weeks of meaningful lifestyle change or appropriate medication. Body composition typically changes over months.

Question 22

What is the role of nutrition?

Accepted Answer

Multiple dietary patterns can support metabolic health. Adherence and overall quality matter more than the specific macronutrient ratio. A clinician or registered dietitian can help individualize the plan.

Question 23

Are weight-loss supplements effective?

Accepted Answer

Most over-the-counter weight-loss supplements are not supported by high-quality evidence and some carry safety risks. Discuss any supplement with a clinician, especially if you take prescription medications.

Question 24

How is sleep apnea connected to metabolic disease?

Accepted Answer

Obstructive sleep apnea is more common in people with obesity and contributes to hypertension, insulin resistance, and daytime fatigue. Treatment — most commonly CPAP — often improves multiple metabolic markers.

Question 25

When should I be screened for type 2 diabetes?

Accepted Answer

Major guidelines recommend screening adults age 35 and older, or younger adults with risk factors such as overweight/obesity, family history, certain ethnic backgrounds, gestational diabetes history, or polycystic ovary syndrome.

Question 26

Is fatty liver reversible?

Accepted Answer

Early MASLD can improve with weight loss, treatment of comorbidities, and reduction in alcohol intake. Advanced fibrosis is harder to reverse, which is why earlier identification matters.

Question 27

Do family members need screening?

Accepted Answer

First-degree relatives of people with type 2 diabetes or premature cardiovascular disease often have elevated risk and may benefit from earlier or more frequent screening.

Question 28

Is endoscopic sleeve gastroplasty the same as bariatric surgery?

Accepted Answer

No. ESG is a minimally invasive endoscopic procedure performed through the mouth, with no surgical incisions. It generally produces less weight loss than surgery but has shorter recovery.

Question 29

Can metabolic disease be cured?

Accepted Answer

Metabolic conditions are generally considered chronic and best described in terms of control and, in some cases, remission rather than cure. Sustained outcomes require sustained care.

Question 30

Where can I learn more from authoritative sources?

Accepted Answer

Reliable sources include the American Diabetes Association (ADA), the American Association of Clinical Endocrinology (AACE), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institutes of Health (NIH), and the World Health Organization (WHO). See our References page for links.

Metabolic Health — Frequently Asked Questions

Medical Review & Clinical Oversight

Medical Reviewers

References